Clinical Trials on Vascular Endothelial Growth Factor Overexpression in Sweden
Total 8 results
-
Umeå UniversityUniversity of EdinburghCompleted
-
Lund UniversityCompletedHypertension | Cardiovascular Risk FactorSweden
-
Lund UniversityCompletedHypertension | Cardiovascular Risk FactorSweden
-
Karolinska InstitutetKarolinska University Hospital; Novo Nordisk A/S; The Swedish Research Council; Danderyd Hospital and other collaboratorsRecruitingKidney Diseases | Hypertension | Proteinuria | Endothelial Dysfunction | Oxidative Stress | Nitric Oxide | PreeclampsiaSweden
-
Göteborg UniversityRecruitingStroke | Cognitive Impairment | Risk Factor, Cardiovascular | Stroke, Ischemic | Stroke HemorrhagicSweden
-
Emelie MalstamUniversity of GavleCompletedStroke | Cardiovascular Risk Factor | Non-Communicable DiseasesSweden
-
Merck KGaA, Darmstadt, GermanyCompletedEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal CancerSweden, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Hungary, Poland, Romania, Austria, Belgium, Finland, Netherlands, Slovakia, Greece, Ta... and more
-
AstraZenecaCompletedSmoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Cardiovascular Risk FactorsSweden, France, Russian Federation, Spain, Turkey, United Kingdom, Germany, Norway, Austria, Belgium, Switzerland, Greece